Natrixam Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

One tablet contains 1.5 mg indapamide and 6.935 mg amlodipine besilate equivalent to 5 mg amlodipine.
One tablet contains 1.5 mg indapamide and 13.87 mg amlodipine besilate equivalent to 10 mg amlodipine.
Excipient with known effect: 104.5 mg lactose monohydrate.
Excipients/Inactive Ingredients: Natrixam 1.5 mg / 5 mg modified-release tablets: Tablet core: Hypromellose (E464), Lactose monohydrate, Magnesium stearate (E572), Povidone (E1201), Anhydrous colloidal silica, Calcium hydrogen phosphate dihydrate, Microcrystalline cellulose (E460), Croscarmellose sodium (E468), Pregelatinized maize starch.
Tablet film-coating: Glycerol (E422), Hypromellose (E464), Macrogol 6000, Magnesium stearate (E572), Titanium dioxide (E171).
Natrixam 1.5 mg / 10 mg modified-release tablets: Tablet core: Hypromellose (E464), Lactose monohydrate, Magnesium stearate (E572), Povidone (E1201), Anhydrous colloidal silica, Calcium hydrogen phosphate dihydrate, Microcrystalline cellulose (E460), Croscarmellose sodium (E468), Pregelatinized maize starch.
Tablet film-coating: Glycerol (E422), Hypromellose (E464), Iron oxide red (E172), Macrogol 6000, Magnesium stearate (E572), Titanium dioxide (E171).

Manufacturer:

Servier

Distributor:

Zuellig Pharma